GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuren Pharmaceuticals Ltd (ASX:NEU) » Definitions » Total Receivables

Neuren Pharmaceuticals (ASX:NEU) Total Receivables : A$22.4 Mil (As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Neuren Pharmaceuticals Total Receivables?

Neuren Pharmaceuticals's Total Receivables for the quarter that ended in Jun. 2024 was A$22.4 Mil.


Neuren Pharmaceuticals Total Receivables Historical Data

The historical data trend for Neuren Pharmaceuticals's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuren Pharmaceuticals Total Receivables Chart

Neuren Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 0.77 1.44 1.10 14.67

Neuren Pharmaceuticals Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.41 1.10 10.45 14.67 22.39

Neuren Pharmaceuticals Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Neuren Pharmaceuticals Total Receivables Related Terms

Thank you for viewing the detailed overview of Neuren Pharmaceuticals's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Neuren Pharmaceuticals Business Description

Traded in Other Exchanges
Address
697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124
Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products.

Neuren Pharmaceuticals Headlines

From GuruFocus

Q2 2022 NewMarket Corp Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q3 2021 NewMarket Corp Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q2 2020 NewMarket Corp Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q4 2021 NewMarket Corp Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q1 2022 NewMarket Corp Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q2 2024 NewMarket Corp Earnings Call Transcript

By GuruFocus Research 07-31-2024

Q3 2020 NewMarket Corp Earnings Call Transcript

By GuruFocus Research 02-10-2024

NewMarket Corporation Declares Quarterly Dividend

By Business Wire 04-25-2024